Dexcom’s Continuous Glucose Monitoring System Gets FDA Clearance
The FDA has cleared Dexcom’s next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with all types of diabetes.
Read MoreDec 9, 2022 | FDA Updates, Patient Safety | 0 |
The FDA has cleared Dexcom’s next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with all types of diabetes.
Read MoreOct 21, 2022 | Remote Monitoring | 0 |
GE Healthcare and AMC Health announced a collaboration that allows clinicians to offer remote patient monitoring for the home environment.
Read MoreInsulet issued a voluntary medical device correction letter for customers of the Omnipod DASH Insulin Management System.
Read MoreSep 22, 2022 | Cybersecurity, Medical Equipment | 0 |
The U.S. FDA is alerting medical device users about a cybersecurity risk for the Medtronic MiniMed 600 Series Insulin Pump System.
Read MoreSep 12, 2022 | Company News, Patient Safety | 0 |
According to a stockholder rights law firm, Medtronic made a number of materially false or misleading statements about its business.
Read More